Jan Dimberg
Impact in
- Pharmacology top 10%
- Inflammatory mediators and NSAID effects
-
- Cancer, Lipids, and Metabolism
Papers in
- Oncology 7
- Colorectal Cancer Treatments and Studies 3
- Cancer Immunotherapy and Biomarkers 2
- Chemokine receptors and signaling 2
- Co-authors
- Anders Hugander (6 shared papers)Peter Söderkvist (6 shared papers)Andreas Matussek (11 shared papers)Dick Wågsäter (11 shared papers)Sture Löfgren (8 shared papers)Roland E. Andersson (9 shared papers)Marita Skarstedt (7 shared papers)Niklas Zar (6 shared papers)
- Journals
- Anticancer Research (3 papers)Apmis (2 papers)International Journal of Colorectal Disease (2 papers)Journal of Vascular Research (2 papers)International Journal of Molecular Medicine (2 papers)
- Partner nations
- SwedenVietnamUnited States
In The Last Decade
Jan Dimberg
32 papers receiving 503 citations
Peers
Comparison fields: 5 of 71
- Pharmacology 116
- Cancer Research 87
- Oncology 110
- Pathology and Forensic Medicine 51
- Immunology 58
Countries citing papers authored by Jan Dimberg
This map shows the geographic impact of Jan Dimberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan Dimberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan Dimberg more than expected).
Fields of papers citing papers by Jan Dimberg
This network shows the impact of papers produced by Jan Dimberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan Dimberg. The network helps show where Jan Dimberg may publish in the future.
Co-authors
The 25 scholars most cited alongside Jan Dimberg, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 32 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1999 | 119 | |
| 2 | Enhanced expression of cyclooxygenase-2 and nuclear beta-catenin are related to mutations in the APC gene in human colorectal cancer. | 2001 | 43 |
| 3 | 2011 | 28 | |
| 4 | 2007 | 25 | |
| 5 | 2011 | 24 | |
| 6 | 2018 | 24 | |
| 7 | 2019 | 22 | |
| 8 | Gene polymorphism of matrix metalloproteinase-12 and -13 and association with colorectal cancer in Swedish patients. | 2013 | 21 |
| 9 | 2012 | 20 | |
| 10 | 2019 | 20 | |
| 11 | 1994 | 18 | |
| 12 | 2015 | 16 | |
| 13 | 2017 | 15 | |
| 14 | 2016 | 14 | |
| 15 | 2018 | 14 | |
| 16 | 2019 | 13 | |
| 17 | 2016 | 13 | |
| 18 | 2016 | 11 | |
| 19 | 2015 | 9 | |
| 20 | 2006 | 7 |
About Jan Dimberg
Jan Dimberg is a scholar working on Molecular Biology, Oncology, Pharmacology, Cancer Research and Pathology and Forensic Medicine, having authored 32 papers that have together received 512 indexed citations. Recurring topics across this work include Inflammatory mediators and NSAID effects (5 papers), Colorectal Cancer Treatments and Studies (3 papers), Genetic factors in colorectal cancer (3 papers), Helicobacter pylori-related gastroenterology studies (2 papers), Protease and Inhibitor Mechanisms (2 papers), Cancer Immunotherapy and Biomarkers (2 papers), Estrogen and related hormone effects (2 papers) and Chemokine receptors and signaling (2 papers). The work is most often cited by research in Pharmacology (116 citations), Cancer Research (87 citations), Oncology (110 citations), Pathology and Forensic Medicine (51 citations) and Immunology (58 citations). Jan Dimberg has collaborated with scholars based in Sweden, Vietnam and United States. Frequent co-authors include Anders Hugander, Peter Söderkvist, Andreas Matussek, Dick Wågsäter, Sture Löfgren, Roland E. Andersson, Marita Skarstedt, Niklas Zar, Allan Sirsjö and Renate Slind Olsen. Their work appears in journals such as Anticancer Research, Apmis, International Journal of Colorectal Disease, Journal of Vascular Research and International Journal of Molecular Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.